Lorenzo Trippa

7PUBLICATIONS
65CO-AUTHORS
Regenerative medicine (incl. stem cells)Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 12, 2026
Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial.

|Mar 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma.

Floris Chabrun, Daniel E Schwartz, Susanna Gentile

|Oct 21, 2024
Toxicity Adaptive Lists Design: A Practical Design for Phase I Drug Combination Trials in Oncology.

Massimiliano Russo, Francesco Mariani, James M Cleary

|Mar 20, 2023
Accessible Data Collections for Improved Decision Making in Neuro-Oncology Clinical Trials.

Rifaquat Rahman, Steffen Ventz, Robert Redd

|Jun 02, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial.

Sara M Tolaney, Nabihah Tayob, Chau Dang

|Jun 27, 2018
Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data.

Thomas Madsen, Danielle Braun, Gang Peng

Pageof 2

Frequent Collaborators

2 joint publications

Irene M Ghobrial

2 joint publications

David M Cordas Dos Santos

1 joint publications

Sara M Tolaney

1 joint publications

Nabihah Tayob